Sobi
The Medical Science Liaison (MSL) at Sobi in Austria is responsible for engaging with scientific stakeholders, including KOLs and medical experts, mainly in Nephrology, to communicate scientific and medical information, support research activities, and represent the company at congresses and advisory boards. The role involves developing strategic relationships and providing medical insights internally and externally.
Headquarters
Stockholm, Stockholm, Sweden
Company Size
1001-5000 employees
Founded
2009
Sobi is a specialised international biopharmaceutical company focused on transforming the lives of people with rare diseases by developing and delivering innovative medicines. The company invests heavily in R&D and maintains a strong pipeline, with expanded patient access and commercialization as core priorities. Headquartered in Stockholm, Sobi operates globally and partners with healthcare providers, patient communities and other stakeholders to bring novel therapies to market. It also emphasizes sustainability, transparency and investor engagement as part of its long‑term strategy.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sobi.
Medical Science Liaison
Sanofi
Director, Medical Science Liaison, (NY, Southern Connecticut)
Revolution Medicines
Director, Medical Science Liaison (IL, IN)
Revolution Medicines
Medical Science Liaison – Gulf Coast Region
Beam Therapeutics
Director, Medical Science Liaison (NC, TN, KY, VA)
Revolution Medicines
Medical Science Liaison, Austria
Revolution Medicines